Profile picture

Professor Nicholas Sibinga

(United States of America)
Follow
Logo ESC

Contributor content

PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling<sup> </sup>
Journal
PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling<sup> </sup>
3 September 2021
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources